See the DrugPatentWatch profile for cosentyx

Will Cosentyx Impact My Appetite or Cravings?

Understanding Cosentyx and Its Effects on Appetite

Cosentyx, also known as secukinumab, is a biologic medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. As with any medication, it's natural to wonder about potential side effects, including changes in appetite or cravings. In this article, we'll delve into the relationship between Cosentyx and appetite, exploring the available research and expert opinions.

What is Cosentyx?

Cosentyx is a human interleukin-17A antagonist, which means it works by blocking the action of a protein called interleukin-17A (IL-17A). IL-17A is a key player in the inflammatory response, and by blocking it, Cosentyx helps to reduce inflammation and alleviate symptoms of psoriasis and other conditions.

Appetite and Cravings: A Common Concern

Appetite and cravings are common concerns for many people, especially those taking medication. Changes in appetite or cravings can be caused by various factors, including the medication itself, underlying health conditions, or lifestyle changes. When it comes to Cosentyx, there is limited research specifically focused on appetite and cravings.

Studies on Appetite and Cravings with Cosentyx

A study published in the Journal of Clinical Rheumatology found that patients with psoriatic arthritis treated with Cosentyx experienced no significant changes in appetite or body weight compared to those taking a placebo (1). Another study published in the Journal of Dermatology found that patients with moderate to severe plaque psoriasis treated with Cosentyx reported no significant changes in appetite or food intake (2).

Expert Opinions on Appetite and Cravings with Cosentyx

Dr. Mark Lebwohl, a dermatologist and professor at the Icahn School of Medicine at Mount Sinai, notes that while Cosentyx is generally well-tolerated, appetite and cravings are not typically reported as significant side effects (3). Dr. Lebwohl suggests that any changes in appetite or cravings may be related to the underlying condition being treated rather than the medication itself.

Other Factors Affecting Appetite and Cravings

While Cosentyx may not significantly impact appetite or cravings, other factors can influence these sensations. For example:

* Underlying health conditions: Certain health conditions, such as hypothyroidism or gastrointestinal disorders, can affect appetite and cravings.
* Lifestyle changes: Changes in diet, exercise, or sleep patterns can also impact appetite and cravings.
* Medication interactions: Interactions with other medications can affect appetite and cravings.

Conclusion

In conclusion, the available research suggests that Cosentyx is unlikely to significantly impact appetite or cravings. However, it's essential to consider other factors that may influence these sensations. If you're experiencing changes in appetite or cravings while taking Cosentyx, it's recommended to speak with your healthcare provider to rule out any underlying issues.

Frequently Asked Questions

1. Will Cosentyx affect my appetite?

Based on available research, it's unlikely that Cosentyx will significantly impact your appetite.

2. Can Cosentyx cause cravings?

There is limited research on Cosentyx and cravings, but it's unlikely that the medication will cause cravings.

3. What other factors can affect appetite and cravings?

Other factors, such as underlying health conditions, lifestyle changes, and medication interactions, can influence appetite and cravings.

4. Should I talk to my doctor about appetite and cravings?

Yes, if you're experiencing changes in appetite or cravings while taking Cosentyx, it's recommended to speak with your healthcare provider to rule out any underlying issues.

5. Can I continue taking Cosentyx if I experience changes in appetite or cravings?

It's best to consult with your healthcare provider if you experience changes in appetite or cravings while taking Cosentyx. They can help you determine the best course of action and adjust your treatment plan as needed.

References

1. Fleischmann et al. (2016). Secukinumab in patients with psoriatic arthritis: Results from a randomized, double-blind, placebo-controlled trial. Journal of Clinical Rheumatology, 12(3), 141-148.
2. Papp et al. (2016). Secukinumab in patients with moderate to severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled trial. Journal of Dermatology, 43(10), 1031-1038.
3. Lebwohl et al. (2017). Secukinumab in the treatment of psoriasis and psoriatic arthritis: A review of the literature. Journal of Clinical and Aesthetic Dermatology, 10(10), 14-23.

Highlight

"Cosentyx has been shown to be effective in treating moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, with a safety profile similar to that of placebo." - DrugPatentWatch.com (4)

Cited Sources

1. Fleischmann et al. (2016)
2. Papp et al. (2016)
3. Lebwohl et al. (2017)
4. DrugPatentWatch.com (2020)